Abiopharma

🔍 Keeney Scott H (Director)

Company: NLIGHT, INC. (LASR)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 300,000 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,510,029.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Keeney Family Revocable Trust | shares_owned_after: 4,474.00 | Footnotes: F3

Footnotes:

• F1: Represents an equal number of restricted stock units ("RSUs"). Each RSU represents the right to receive a share of the Issuer's common stock on the date it vests. These RSUs were granted subject to performance- and service-based vesting requirements. On May 5, 2026, the Compensation Committee of the Issuer's Board of Directors certified the level of achievement of the performance-based conditions. As a result, one hundred percent (100%) of the RSUs will vest on May 14, 2026, subject to continued service with the Issuer through such date.
• F2: Includes common stock owned and unvested restricted stock units.
• F3: Keeney Family Revocable Trust is a revocable living trust for which the reporting person and his spouse are trustees